指南与共识前列腺增生与排尿功能障碍

AUA指南第一部分:良性前列腺增生所致下尿路症状的初始评估与药物治疗

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
指南 / 共识 · J Urol · 2021-08-13

PURPOSE: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone.…

要点

  • 指南涵盖BPH/LUTS的评估、初始检查与药物治疗,共19条声明。
  • 证据强度分为A(高)、B(中)、C(低),推荐强度分为强、中、条件性。
  • 无充分证据时以临床原则和专家意见形式提供指导。

核心结论

  • BPH所致LUTS的评估和药物治疗需关注患者个体特征,同时遵循共同原则。
  • 临床医生应遵循指南推荐并熟悉BPH管理标准。

研究设计与样本

  • 检索词包括药理学治疗、药物类别及LUTS或BPH相关的MeSH主题词和关键词。
  • 证据充分时给予A(高)、B(中)、C(低)证据强度分级,对应强、中、条件性推荐;证据不足时以临床原则和专家意见提供信息。

主要发现

  • 制定了19条与评估、检查和药物治疗相关的指南声明。
  • 为初级保健和泌尿外科医生提供了适当的证据水平和支持文本,以指导简化和合适的管理实践。

关键数值与推荐

  • 证据强度分级:A(高)、B(中)、C(低),分别支持强、中、条件性推荐。
  • 证据不足时,信息以临床原则和专家意见形式提供。

临床怎么用

  • 临床医生应遵循指南推荐,熟悉BPH管理标准,对BPH所致LUTS患者进行个体化评估和药物治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are progressive and impact the health and welfare of society. This revised Guideline provides a useful reference on effective evidence-based management of male LUTS/BPH. See the accompanying algorithm for a summary of the procedures detailed in the Guideline (figures 1 and 2[Figure: see text][Figure: see text]). MATERIALS AND METHODS: The Minnesota Evidence Review Team searched Ovid MEDLINE, Embase, Cochrane Library, and AHRQ databases to identify eligible English language studies published between January 2008 and April 2019, then updated through December 2020. Search terms included Medical Subject Headings (MeSH) and keywords for pharmacological therapies, drug classes, and terms related to LUTS or BPH. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, information is provided as Clinical Principles and Expert Opinions (table 1[Table: see text]). RESULTS: Nineteen guideline statements pertinent to evaluation, work-up, and medical management were developed. Appropriate levels of evidence and supporting text were created to direct both primary care and urologic providers towards streamlined and suitable practices. CONCLUSIONS: The work up and medical management of BPH requires attention to individual patient characteristics, while also respecting common principles. Clinicians should adhere to recommendations and familiarize themselves with standards of BPH management.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Lerner LB, McVary KT, Barry MJ, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol. 2021. PMID: 34384237. doi:10.1097/JU.0000000000002183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。